Industry Seeks to Stimulate Innovation Through Grant Programs

Last month, Thermo Fisher Scientific announced that its Oncomine Clinical Research Grant Program was open for submissions.

The grant program, launched in 2020 to support research on molecular diagnostics for cancer treatment, is one of several funding initiatives launched by biotech and pharma companies in recent years. Supporting researchers in academia and startups, these initiatives span from forensic sciences to artificial intelligence, reaching values of more than half a million dollars.